Analysis of Opioid Use in Patients Undergoing Open Versus Robotic Gastrectomy-Reference-Cited by-同舟云学术

Analysis of Opioid Use in Patients Undergoing Open Versus Robotic Gastrectomy

Published:2022-05-04 Issue:9 Volume:29 Page:5861-5870
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Hirata Yuki,Witt Russell G.,Prakash Laura R.,Arvide Elsa M.,Robinson Kristen A.,Gottumukkala Vijaya,Tzeng Ching-Wei D.,Mansfield Paul,Badgwell Brian D.,Ikoma Naruhiko

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-022-11836-2.pdf

Reference61 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

2. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, Participants MT. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.

3. Al-Batran S-E, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. The Lancet. 2019;393:1948–57.

4. Leong T, Smithers BM, Michael M, Gebski V, Boussioutas A, Miller D, et al. TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG). BMC Cancer. 2015;15:532.

5. Kang YK, Yook JH, Park YK, Lee JS, Kim YW, Kim JY, et al. PRODIGY: a phase III study of neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 versus surgery and adjuvant S-1 for resectable advanced gastric cancer. J Clin Oncol. 2021;39:2903–13.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of and Factors Associated with Financial Toxicity After Pancreatectomy and Gastrectomy;Annals of Surgical Oncology;2024-03-27

2. What defines the “value” of robotic surgery for patients with gastrointestinal cancers? Perspectives from a U.S. Cancer Center;Annals of Gastroenterological Surgery;2024-03-21

3. Cost Analysis for Robotic and Open Gastrectomy;Annals of Surgery Open;2024-03

4. Laparoscopic transverse abdominis plane block: how I do it and a cost efficiency analysis;Langenbeck's Archives of Surgery;2023-12-26

5. Opioid-Free Discharge After Pancreatic Resection Through a Learning Health System Paradigm;JAMA Surgery;2023-11-08